CampBridge ELISA     For Campath Biosimilar Comparison

Complete kit for the systematic 3-D conformational comparability analysis of 

Campath biosimilar molecule to Alemtuzumab (Campath trade name)

Alemtuzumab is a humanized monoclonal antibody, produced by Genzyme that targets CD52, 

a cell-surface receptor on lymphocytes. It is used for the treatment of chronic lymphocytic 

leukemia and certain lymphomas. 

This kit will allow for conformational comparison between Campath Biosimilars and 

authentic Alemtuzumab. 

AB000203       CampBridge ELISA (for Campath Biosimilar Comparison)       1 Kit

☞   Click here for detailed product instruction